Patents by Inventor Christopher Corless

Christopher Corless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutics targets
    Publication number: 20060084142
    Abstract: This disclosure provides tyrosine kinase protein and nucleic acid variants, particularly PDGFRA variants, which are activating forms of these molecules and are linked to neoplasms and/or the development or progression of cancer. The disclosure further provides methods of diagnosis and prognosis, and development of new therapeutic agents using these molecules and fragments thereof, and kits for employing these methods and compositions.
    Type: Application
    Filed: June 13, 2003
    Publication date: April 20, 2006
    Applicants: Brigham And Women's Hospital, Oregon Health & Science University, Dana-Farber Cancer Institute
    Inventors: Michael Heinrich, Christopher Corless
  • Use of 4-(4-Methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating seminomas
    Publication number: 20050153975
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used in the treatment of seminomas.
    Type: Application
    Filed: February 17, 2003
    Publication date: July 14, 2005
    Inventors: Michael Heinrich, Christopher Corless, Kathleen Kemmer